Stepwise management of COPD: What is next after bronchodilation?
M Miravitlles, K Matsunaga… - Therapeutic Advances in …, 2023 - journals.sagepub.com
Inhaled bronchodilator therapy with long-acting muscarinic antagonists (LAMAs) and long-
acting β2-agonists (LABAs) in combination is currently the mainstay of treatment for chronic …
acting β2-agonists (LABAs) in combination is currently the mainstay of treatment for chronic …
Analysis of the Comorbid Course of Chronic Obstructive Pulmonary Disease
S Kotlyarov - Journal of Personalized Medicine, 2023 - mdpi.com
(1) Background. Chronic obstructive pulmonary disease (COPD) has a heterogeneous
natural history, manifested both in the variability of clinical features and in association with …
natural history, manifested both in the variability of clinical features and in association with …
Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death–A National Register Study
I Henoch, A Ekberg-Jansson, CG Löfdahl… - International journal of …, 2020 - Taylor & Francis
Background Both single factors and composite measures have been suggested to predict
mortality in patients with chronic obstructive pulmonary disease (COPD) and there is a need …
mortality in patients with chronic obstructive pulmonary disease (COPD) and there is a need …
The effects of metal exposures on charlson comorbidity index using zero-inflated negative binomial regression model: NHANES 2011–2016
H Zhao, Y Pan, C Wang, Y Guo, N Yao… - … Trace Element Research, 2021 - Springer
Background With the rising incidence of chronic diseases, and the increase of aging
population has led to multimorbidity a serious public health problem. The aim of this study …
population has led to multimorbidity a serious public health problem. The aim of this study …
[PDF][PDF] 慢性阻塞性肺疾病稳定期患者共患疾病与死亡风险的关系研究
李然， 刘晓芳， 王玉红， 白澎 - 临床内科杂志, 2022 - lcnkzz.com
目的探讨慢性阻塞性肺疾病(简称慢阻肺) 共患疾病与死亡风险的关系. 方法纳入慢阻肺稳定期
患者166 例, 收集其临床资料, 统计共患疾病数量, 种类及英国医学研究委员会呼吸困难量表 …
患者166 例, 收集其临床资料, 统计共患疾病数量, 种类及英国医学研究委员会呼吸困难量表 …
Polypharmacy among older individuals with COPD: trends between 2000 and 2015 in Quebec, Canada
The treatment of chronic obstructive pulmonary disease (COPD) and concomitant diseases
requires several medications. Yet there is little data on how the pharmacological burden …
requires several medications. Yet there is little data on how the pharmacological burden …
Niacin, lutein and zeaxanthin and physical activity have an impact on Charlson comorbidity index using zero-inflated negative binomial regression model: National …
H Zhao, C Wang, Y Pan, Y Guo, N Yao, H Wang, L Jin… - BMC Public Health, 2019 - Springer
Background Combined with the increasing life expectancy, chronic medical conditions have
gradually become the dominant cause of death and disability, and multimorbidity became an …
gradually become the dominant cause of death and disability, and multimorbidity became an …
La nutrición como parte del manejo integral del paciente con enfermedad pulmonar obstructiva crónica: revisión narrativa
CEA Franco - Medicina, 2023 - revistamedicina.net
La enfermedad pulmonar obstructiva crónica (EPOC) es una patología de expresión
multisistémica, producto de la exposición del pulmón a partículas o gases nocivos, e …
multisistémica, producto de la exposición del pulmón a partículas o gases nocivos, e …
Risk of all-cause mortality associated with chronic obstructive pulmonary disease and the role of healthy ageing trajectories: a population-based study of middle-aged …
Objectives The aims were to study the risk of all-cause mortality associated with chronic
obstructive pulmonary disease (COPD) and healthy ageing trajectories (HAT) in three birth …
obstructive pulmonary disease (COPD) and healthy ageing trajectories (HAT) in three birth …
[PDF][PDF] 重叠综合征与单纯慢性阻塞性肺疾病共病比较
杨海珍， 岳芳， 郝玥影， 张庆丰， 张静怡， 胡克 - 临床内科杂志, 2023 - lcnkzz.com
目的探讨重叠综合征(OVs) 与单纯慢性阻塞性肺疾病(COPD) 患者共病患病率的差异及呼吸暂停
低通气指数(AHI), 脉搏血氧饱和度(spO2)< 90% 占总睡眠时间的百分比(T90) …
低通气指数(AHI), 脉搏血氧饱和度(spO2)< 90% 占总睡眠时间的百分比(T90) …